Luísa Alves

Luísa Alves

Auto-generated profile, based on publicly available information

Luísa Alves

Chronic Diseases Research Centre, NOVA Medical School, NOVA University of Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2015 in American Journal of Alzheimer's Disease and Other Dementias®
Verified
Journal Article
Closed access
MMMarcelo Mendonça
Marcelo Mendonça
LALuísa Alves
Luísa Alves
PBPaulo Bugalho
Paulo Bugalho
Subjective cognitive complaints (SCCs) are frequent in the elderly population. The majority of individuals with subjective complaints never progress to significant cognitive decline, but some of them have a higher risk of progression to objective cognitive impairment than persons with no cognitive concerns. We performed a systematic review of community-based studies that focused on the progression risk associated with SCC and on the complainers’ characteristics associated with progression. Seventeen studies were included. As a group, SCCs are associated with a significantly higher risk of progression to dementia. Worried complainers, persons who refer an impact of their complaints on activities of daily living, and those whose complaints are also noticed by an informant have the highest risk of progression. Taking into account the fluctuating course of SCC and their frequent reversion, care should be taken to not overvaluate them. Further studies are necessary to better define risk features.

1 January 2012 in Frontiers in Neurology
Verified
Journal Article
Open access
LALuísa Alves
Luísa Alves
ACAna Sofia A. Correia
Ana Sofia A. Correia
RMRita Miguel
Rita Miguel
PAPaulo Alegria
Paulo Alegria
PBPaulo Bugalho
Paulo Bugalho
Investigation in the field of Alzheimer’s disease (AD), the commonest cause of dementia, has been very active in recent years and it may be difficult for the clinician to keep up with all the innovations and to be aware of the implications they have in clinical practice. The authors, thus, reviewed recent literature on the theme in order to provide the clinician with an updated overview, intended to support decision-making on aspects of diagnosis and management. This article begins to focus on the concept of AD and on its pathogenesis. Afterward, epidemiology and non-genetic risk factors are approached. Genetics, including genetic risk factors and guidelines for genetic testing, are mentioned next. Recommendations for diagnosis of AD, including recently proposed criteria, are then reviewed. Data on the variants of AD is presented. First approach to the patient is dealt with next, followed by neuropsychological evaluation. Biomarkers, namely magnetic resonance imaging, single photon emission tomography, FDG PET, PiB PET, CSF tau, and Aβ analysis, as well as available data on their diagnostic accuracy, are also discussed. Factors predicting rate of disease progression are briefly mentioned. Finally, non-pharmacological and pharmacological treatments, including established and emerging drugs, are addressed.

20 January 2013 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
PBPaulo Bugalho
Paulo Bugalho
LALuísa Alves
Luísa Alves
RMRita Miguel
Rita Miguel

1 March 2014 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
PBPaulo Bugalho
Paulo Bugalho
LALuísa Alves
Luísa Alves
RMRita Miguel
Rita Miguel
OROlga Ribeiro
Olga Ribeiro

1 March 2019 in Sleep Medicine
Verified
Journal Article
Closed access
PBPaulo Bugalho
Paulo Bugalho
MSManuel Salavisa
Manuel Salavisa
JMJoão Pedro Marto
João Pedro Marto
CBClaudia Borbinha
Claudia Borbinha
LALuísa Alves
Luísa Alves

26 June 2020 in Journal of Neuropsychology
Verified
Journal Article
Closed access
PDF file
LALuísa Alves
Luísa Alves
SCSandra Cardoso
Sandra Cardoso
DSDina Silva
Dina Silva
TMTiago Mendes
Tiago Mendes
João MarôcoJoão Marôco
João Marôco
MGManuela Guerreiro
Manuela Guerreiro